Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Future treatment for asthma

Abstract : The landscape of asthma has considerably changed after 40 years of inhaled corticosteroid development and nearly 20 years since the first monoclonal antibodies (mAbs) were approved. New members of pharmacological families and more effective drug-delivery devices have been designed but the proportion of uncontrolled patients, unfortunately, remains stable. The most promising treatments now rely on targeted therapies that encourage the improvement of the characterisation of our patients. These clinical (phenotype) or new biological (endotype) tools lead to palpable personalised medicine. This review examines not only the future of mAbs and other new ways of treating asthma but also describes futuristic views based on the paradigm shifts that are ready to occur.
Type de document :
Article dans une revue
Liste complète des métadonnées
Contributeur : Dominique Mornet <>
Soumis le : mercredi 11 mars 2020 - 14:41:17
Dernière modification le : vendredi 15 mai 2020 - 12:22:08
Archivage à long terme le : : vendredi 12 juin 2020 - 15:46:08


2016 Charriot et al., Futur tr...
Fichiers produits par l'(les) auteur(s)




Jérémy Charriot, Isabelle Vachier, Laurence Halimi, Anne-Sophie Gamez, Clement Boissin, et al.. Future treatment for asthma. European Respiratory Review, European Respiratory Society, 2016, 25 (139), pp.77 - 92. ⟨10.1183/16000617.0069-2015⟩. ⟨hal-01783974⟩



Consultations de la notice


Téléchargements de fichiers